# CLF065 for Chronic Pouchitis

> **NCT07226050** · PHASE2 · RECRUITING · sponsor: **Calibr, a division of Scripps Research** · enrollment: 20 (estimated)

## Conditions studied

- Pouchitis

## Interventions

- **DRUG:** CLF065
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07226050
- **Lead sponsor:** Calibr, a division of Scripps Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-05
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07226050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07226050, "CLF065 for Chronic Pouchitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07226050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*